Bacterial ghosts as vaccine candidates for veterinary applications

被引:94
作者
Jalava, K
Hensel, A
Szostak, M
Resch, S
Lubitz, W
机构
[1] BIRD C GmbH & CoKEG, Biotech Innovat Res Dev & Consulting, A-1080 Vienna, Austria
[2] Univ Leipzig, Fac Med Vet, Inst Anim Hyg & Publ Vet Hlth, D-04103 Leipzig, Germany
[3] Apovia AG, D-82152 Martinsried, Germany
[4] Univ Vienna, Inst Microbiol & Genet, A-1090 Vienna, Austria
关键词
bacterial ghosts; vaccines; mucosal immunity;
D O I
10.1016/S0168-3659(02)00267-5
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The application of new strategies to develop effective vaccines is essential in modem veterinary medicine. The bacterial ghost system is a novel vaccine delivery system endowed with intrinsic adjuvant properties. Bacterial ghosts are nonliving Gram-negative bacterial cell envelopes devoid of cytoplasmic contents while maintaining their cellular morphology and native surface antigenic structures including bioadhesive properties. They are produced by PhiX174 protein E-mediated lysis of Gram-negative bacteria. The intrinsic adjuvant properties of bacterial ghost preparations enhance immune responses against envelope bound antigens, including T-cell activation and mucosal immunity. Since native and foreign antigens can be expressed in the envelope complex of ghosts before E-mediated lysis, multiple antigens of various origins can be presented to the immune system simultaneously. The advantages of bacterial ghosts include the simplicity of the production method, safety, independence from the cold chain. and versatility as a combination vaccine. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:17 / 25
页数:9
相关论文
共 38 条
[1]  
[Anonymous], 1989, Pasteurella and pasteurellosis
[2]  
BARILE MF, 1985, MYCOPLASMAS, V4, P451
[3]   A FAMILY OF PHASE-VARIANT AND SIZE-VARIANT MEMBRANE-SURFACE LIPOPROTEIN ANTIGENS (VSPS) OF MYCOPLASMA-BOVIS [J].
BEHRENS, A ;
HELLER, M ;
KIRCHHOFF, H ;
YOGEV, D ;
ROSENGARTEN, R .
INFECTION AND IMMUNITY, 1994, 62 (11) :5075-5084
[4]   Genetic evidence that the bacteriophage φX174 lysis protein inhibits cell wall synthesis [J].
Bernhardt, TG ;
Roof, WD ;
Young, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (08) :4297-4302
[5]  
DUCKWORTH J, 2001, BIOL MANAGEMENT POSS
[6]  
Haslberger AG, 1997, J ENDOTOXIN RES, V4, P431, DOI 10.1177/096805199700400607
[7]   Activation, stimulation and uptake of bacterial ghosts in antigen presenting cells [J].
Haslberger, AG ;
Kohl, G ;
Felnerova, D ;
Mayr, UB ;
Fürst-Ladani, S ;
Lubitz, W .
JOURNAL OF BIOTECHNOLOGY, 2000, 83 (1-2) :57-66
[8]   Induction of protective immunity by aerosol or oral application of candidate vaccines in a dose-controlled pig aerosol infection model [J].
Hensel, A ;
vanLeengoed, LAMG ;
Szostak, M ;
Windt, H ;
Weissenbock, H ;
StockhofeZurwieden, N ;
Katinger, A ;
Stadler, M ;
Ganter, M ;
Bunka, S ;
Pabst, R ;
Lubitz, W .
JOURNAL OF BIOTECHNOLOGY, 1996, 44 (1-3) :171-181
[9]   Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state [J].
Hensel, A ;
Huter, V ;
Katinger, A ;
Raza, P ;
Strnistschie, C ;
Roesler, U ;
Brand, E ;
Lubitz, W .
VACCINE, 2000, 18 (26) :2945-2955
[10]   Bacterial ghosts as drug carrier and targeting vehicles [J].
Huter, V ;
Szostak, MP ;
Gampfer, J ;
Prethaler, S ;
Wanner, G ;
Gabor, F ;
Lubitz, W .
JOURNAL OF CONTROLLED RELEASE, 1999, 61 (1-2) :51-63